IGC Pharma Inc (IGC)
0.3561
0.00 (0.00%)
USD |
NYAM |
Nov 22, 12:18
IGC Pharma Gross Profit Margin (Quarterly): 48.06% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 48.06% |
| June 30, 2024 | 59.93% |
| March 31, 2024 | 57.97% |
| December 31, 2023 | 65.20% |
| September 30, 2023 | 59.79% |
| June 30, 2023 | 45.95% |
| March 31, 2023 | 37.95% |
| December 31, 2022 | 30.72% |
| September 30, 2022 | 66.83% |
| June 30, 2022 | 66.98% |
| March 31, 2022 | 55.74% |
| December 31, 2021 | 43.66% |
| September 30, 2021 | 67.86% |
| June 30, 2021 | 33.77% |
| March 31, 2021 | 33.33% |
| December 31, 2020 | 12.96% |
| September 30, 2020 | 20.80% |
| June 30, 2020 | 7.88% |
| March 31, 2020 | 55.17% |
| December 31, 2019 | 5.24% |
| September 30, 2019 | 1.54% |
| June 30, 2019 | 2.49% |
| March 31, 2019 | 1.75% |
| December 31, 2018 | 3.50% |
| September 30, 2018 | 2.22% |
| Date | Value |
|---|---|
| June 30, 2018 | 2.84% |
| March 31, 2018 | -6.66% |
| December 31, 2017 | 5.12% |
| September 30, 2017 | 30.64% |
| June 30, 2017 | 87.00% |
| March 31, 2017 | 7.84% |
| December 31, 2016 | 51.23% |
| September 30, 2016 | 44.17% |
| June 30, 2016 | 30.03% |
| March 31, 2016 | 19.55% |
| December 31, 2015 | 18.99% |
| September 30, 2015 | 8.07% |
| June 30, 2015 | 10.98% |
| March 31, 2015 | 5.44% |
| December 31, 2014 | 7.83% |
| September 30, 2014 | 8.56% |
| June 30, 2014 | 10.02% |
| March 31, 2014 | |
| December 31, 2013 | 55.57% |
| September 30, 2013 | 16.77% |
| June 30, 2013 | 16.70% |
| March 31, 2013 | 14.61% |
| December 31, 2012 | 18.91% |
| September 30, 2012 | 17.99% |
| June 30, 2012 | 26.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
5.24%
Minimum
Dec 2019
67.86%
Maximum
Sep 2021
43.79%
Average
47.00%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 77.14% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Protalix BioTherapeutics Inc | 53.37% |
| Palatin Technologies Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -137.4% |
| Return on Assets | -107.2% |
| Return on Invested Capital | -135.4% |
| Profit Margin (Quarterly) | -416.7% |
| Operating Margin (Quarterly) | -427.2% |
| Return on Net Operating Assets | -135.4% |